This discovery reveals a novel paradigm of direct regulation of apoptotic executive proteins by microbial metabolites, and offers a new perspective that ILA shows better clinical translational potential due to its clear molecular target, compared with the traditional probiotic transplantation strategy for targeted treatment of AP intestinal injury. Here, TNFRSF9 is linked to alkaline phosphatase measurement.